✦ LIBER ✦

1867 – Motor procedural learning in individuals with mild and moderate alzheimer's disease compared to healthy subjects

✍ Scribed by Pasgreta, K.; Feit, J.; Nowińska, E.; Walecki, P.; Gorzelańczyk, E.J.

Book ID: 122042910
Publisher: Elsevier Science
Year: 2013
Tongue: French
Weight: 55 KB
Volume: 28
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(13)76827-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-1027 - Graphomotor efficiency in indiv

P-1027 - Graphomotor efficiency in individuals with mild and intermediate alzheimer's disease compared to healthy subjects

✍ Pasgreta, K.; Nowińska, E.; Feit, J.; Płaszczyca, N.; Lasoń, W.; Gorzelańczyk, E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 68 KB

Quantitative sensory testing and pain to

Quantitative sensory testing and pain tolerance in patients with mild to moderate Alzheimer disease compared to healthy control subjects

✍ Jensen-Dahm, Christina; Werner, Mads U.; Dahl, Jørgen B.; Jensen, Troels Staehel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Impairment in Emotion Recognition Abilit

Impairment in Emotion Recognition Abilities in Patients With Mild Cognitive Impairment, Early and Moderate Alzheimer Disease Compared With Healthy Comparison Subjects

✍ Weiss, Elisabeth M.; Kohler, Christian G.; Vonbank, Julia; Stadelmann, Edith; Ke 📂 Article 📅 2008 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 92 KB

Safety, efficacy, pharmacokinetics and p

Safety, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of Ponezumab in subjects with mild-to-moderate Alzheimer's disease

✍ Landen, Jaren; Cohen, Sharon; Billing, Clare; Cronenberger, Carol; Styren, Scot; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Secondary endpoint and responder analyse

Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease

✍ Alderton, Claire; Zvartau-Hind, Marina; Ritchie, Sally; Saunders, Ann; Craft, Su 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of Ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease

✍ Landen, Jaren; Andreasen, Niels; Cronenberger, Carol; Schwartz, Pam; Börjesson-H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB